Wisconsin-based Smart Choice MRI hopes to start a low-cost revolution for magnetic resonance imaging (MRI). The startup already has 6 Wisconsin locations where it charges $600 or less for an MRI, as compared to the Wisconsin average, which the company said is almost $3,000. Smart Choice MRI shaves those costs down by not housing its own radiologists--it has a deal with the Cleveland Clinic to provide radiologist interpretation of its MRI images.
A lot of money and energy is being invested in improving upon and supplementing the analysis conducted by radiologists of medical images. The expectation is that computers will offer a more precise and consistent inspection than practiced human eyes that will be applied to ever more sophisticated, timely and complex medical images.
San Francisco-based Enlitic is working to apply the advances in deep learning in recent years to medical imaging. Now it's recruited the fastest-growing Australian radiology services provider, Capitol Health, to aid it in that quest with a partnership and by taking the lead on a $10 million Series B financing.
Amid a growing body of research that shows deposits of gadolinium-based contrast agents (GBCAs) remain in the brain after repeat MRI procedures, the FDA is investigating the products' safety and risks.
Profound Medical went public on the Toronto Stock Exchange last month and raised $25 million in June. Now, it's partnered with Royal Philips to develop its novel, minimally invasive prostate gland ablation tool to be used on Philips' MRI systems.
Cardiac Rhythm & Heart Failure is one of Medtronic's faster growing businesses, driven in part by the launch of tiny subcutaneous heart monitor Reveal Linq. The medical device giant expects that the launch of supersmall leadless pacemaker Micra Transcatheter Pacing System could help it to keep that revenue growth momentum going.
The FDA has approved the Protégé MRI spinal cord stimulation system to treat chronic pain, along with the related MRI compatible leads, from St. Jude Medical. The device also offers the benefit of enabling future updates via wireless software upgrades rather than requiring its replacement to gain the benefits of new developments.
Tal Medical has its roots in the serendipitous discovery that MRI imaging has a fast, mood-elevating effect. So far, it's managed to establish in the clinic that its low-field magnetic stimulation device built to recreate those conditions is rapid-acting. But now it's raised a $14 million Series B round to help establish the durability of that effect and the best dosage for depression treatment.
Almost 10,000 GE and Siemens MRI machines are being recalled, FDA's database shows. The agency classified the recalls in its second-most severe category, meaning the affected machines "may cause temporary or medically reversible adverse health consequences."
The Mayo Clinic has found that gadolinium-based contrast agents used in MRI exams leave deposits in the brain. The researchers said that there is no evidence that the gadolinium deposits are harmful to patients and continues to recommend the use of gadolinium-based contrast agents as appropriate.